<bill session="115" type="h" number="2376" updated="2023-01-11T13:36:48Z">
  <state datetime="2017-05-04">REFERRED</state>
  <status>
    <introduced datetime="2017-05-04"/>
  </status>
  <introduced datetime="2017-05-04"/>
  <titles>
    <title type="display">Drug Diversion and Counterfeit Crackdown Act of 2017</title>
    <title type="official" as="introduced">To amend the Federal Food, Drug, and Cosmetic Act to protect and strengthen the drug supply chain in the United States by closing several statutory gaps in the penalty provisions of such Act that apply to drug diversion and counterfeiting.</title>
    <title type="short" as="introduced">Drug Diversion and Counterfeit Crackdown Act of 2017</title>
  </titles>
  <sponsor bioguide_id="L000567"/>
  <cosponsors>
    <cosponsor bioguide_id="B001248" joined="2017-05-04"/>
    <cosponsor bioguide_id="D000624" joined="2017-05-04"/>
    <cosponsor bioguide_id="G000410" joined="2017-05-04"/>
  </cosponsors>
  <actions>
    <action datetime="2017-05-04">
      <text>Introduced in House</text>
    </action>
    <action datetime="2017-05-04" state="REFERRED">
      <text>Referred to the House Committee on Energy and Commerce.</text>
    </action>
    <action datetime="2017-05-05">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill session="115" type="h" number="2430" relation="unknown"/>
    <bill session="115" type="s" number="934" relation="unknown"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
    <term name="Consumer affairs"/>
    <term name="Drug safety, medical device, and laboratory regulation"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Fraud offenses and financial crimes"/>
    <term name="Manufacturing"/>
  </subjects>
  <amendments/>
  <summary date="2019-04-15T22:32:23Z" status="Introduced in House">Drug Diversion and Counterfeit Crackdown Act of 2017

This bill makes it illegal except in cases of a drug shortage to import into the United States prescription drugs manufactured outside the United States and intended by the manufacturer or labeled to be marketed outside the United States.

The bill establishes a penalty for knowingly dispensing or selling a counterfeit drug.</summary>
</bill>
